FindTrial
Sign In

Fluorescent microscopy in Leprosy.

Fluorescent microscopy versus modified Fite Faraco stain in skin biopsy specimens of Hansen s cases A comparative study. - FML

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/01/017031
Enrollment
60
Registered
2019-01-10
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: A309- Leprosy, unspecified

Interventions

Intervention1: Fluorescent microscopy: Fluorescent microscopy versus modified Fite-Faraco stain in skin biopsy specimens of Hansens cases. Control Intervention1: Modified Fite-Faraco stain: Fluorescen

Sponsors

GSL Medical College
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All clinically suspected (or) diagnosed leprosy patients of any spectrum.

Exclusion criteria

Exclusion criteria: Leprosy patients who are already on treatment (or) completed treatment. Patient is a newly diagnosed cases on steroids. Patient on other immuno supressants.

Design outcomes

Primary

MeasureTime frame
Significance of fluorescence microscopy in the detection of acid fast organisms in tissue sections when compared to Fite-Faraco procedureTimepoint: Jan 2019 to June 2020—

Secondary

MeasureTime frame
Helps in classifying the leprosy disease(paucibacillary or multibacillary) for effective management and preventing complications. Timepoint: Jan 2019 to June 2020—

Countries

India

Contacts

Public ContactDr GVenkata Ramana

GSL MEDICAL COLLEGE AND GENERAL HOSPITAL

sravani.laxmi1993@gmail.com7382466204

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026